Cited by 25Menstrual Health and DisordersMobile Health and mHealth ApplicationsReproductive Health and Contraception

Abnormal uterine bleeding patterns determined through menstrual tracking among participants in the Apple Women’s Health Study

Open access
Zhang, Carey Y., Li, Huichu, Zhang, Shunan, Suharwardy, Sanaa, Chaturvedi, Uvika, Fischer-Colbrie, Tyler, Maratta, Lindsey A., Onnela, Jukka-Pekka +7 more·2023·American Journal of Obstetrics and Gynecology

Abstract

BACKGROUND: Use of menstrual tracking data to understand abnormal bleeding patterns has been limited because of lack of incorporation of key demographic and health characteristics and confirmation of menstrual tracking accuracy. OBJECTIVE: This study aimed to identify abnormal uterine bleeding patterns and their prevalence and confirm existing and expected associations between abnormal uterine bleeding patterns, demographics, and medical conditions. STUDY DESIGN: Apple Women's Health Study participants from November 2019 through July 2021 who contributed menstrual tracking data and did not report pregnancy, lactation, use of hormones, or menopause were included in the analysis. Four abnormal uterine bleeding patterns were evaluated: irregular menses, infrequent menses, prolonged menses, and irregular intermenstrual bleeding (spotting). Monthly tracking confirmation using survey responses was used to exclude inaccurate or incomplete digital records. We investigated the prevalence of abnormal uterine bleeding stratified by demographic characteristics and used logistic regression to evaluate the relationship of abnormal uterine bleeding to a number of self-reported medical conditions. RESULTS: There were 18,875 participants who met inclusion criteria, with a mean age of 33 (standard deviation, 8.2) years, mean body mass index of 29.3 (standard deviation, 8.0), and with 68.9% (95% confidence interval, 68.2-69.5) identifying as White, non-Hispanic. Abnormal uterine bleeding was found in 16.4% of participants (n=3103; 95% confidence interval, 15.9-17.0) after accurate tracking was confirmed; 2.9% had irregular menses (95% confidence interval, 2.7-3.1), 8.4% had infrequent menses (95% confidence interval, 8.0-8.8), 2.3% had prolonged menses (95% confidence interval, 2.1-2.5), and 6.1% had spotting (95% confidence interval, 5.7-6.4). Black participants had 33% higher prevalence (prevalence ratio, 1.33; 95% confidence interval, 1.09-1.61) of infrequent menses compared with White, non-Hispanic participants after controlling for age and body mass index. The prevalence of infrequent menses was increased in class 1, 2, and 3 obesity (class 1: body mass index, 30-34.9; prevalence ratio, 1.31; 95% confidence interval, 1.13-1.52; class 2: body mass index, 35-39.9; prevalence ratio, 1.25; 95% confidence interval, 1.05-1.49; class 3: body mass index, >40; prevalence ratio, 1.51; 95% confidence interval, 1.21-1.88) after controlling for age and race/ethnicity. Those with class 3 obesity had 18% higher prevalence of abnormal uterine bleeding compared with healthy-weight participants (prevalence ratio, 1.18; 95% confidence interval, 1.02-1.38). Participants with polycystic ovary syndrome had 19% higher prevalence of abnormal uterine bleeding compared with participants without this condition (prevalence ratio, 1.19; 95% confidence interval, 1.08-1.31). Participants with hyperthyroidism (prevalence ratio, 1.34; 95% confidence interval, 1.13-1.59) and hypothyroidism (prevalence ratio, 1.17; 95% confidence interval, 1.05-1.31) had a higher prevalence of abnormal uterine bleeding, as did those reporting endometriosis (prevalence ratio, 1.28; 95% confidence interval, 1.12-1.45), cervical dysplasia (prevalence ratio, 1.20; 95% confidence interval, 1.03-1.39), and fibroids (prevalence ratio, 1.14; 95% confidence interval, 1.00-1.30). CONCLUSION: In this cohort, abnormal uterine bleeding was present in 16.4% of those with confirmed menstrual tracking. Black or obese participants had increased prevalence of abnormal uterine bleeding. Participants reporting conditions such as polycystic ovary syndrome, thyroid disease, endometriosis, and cervical dysplasia had a higher prevalence of abnormal uterine bleeding.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajog.2022.10.029

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Where reported, the mean age of participants in mobile app studies ranged from 24.70 ± 5.45 years to 33.0 ± 8.2 years, and mean BMI ranged from 24.2 kg/m2 to 29.3 ± 8.00 kg/m2.

    “Where reported, the mean age (±standard deviation) of participants ranged from 24.70 ± 5.45 years [56] to 33.0 ± 8.2 years [61], whilst the mean body mass index (BMI) ranged from 24.2 kg/m2 [43] to 29.3 ± 8.00 kg/m2 [61].”
  • One phone-based study implies collection of health data and menstrual cycle tracking through apps from iPhone users with an iCloud account.

    “One study, previously described in the context of mobile apps, implies the collection of health data and menstrual cycle tracking through apps from iPhone users with an iCloud account [61].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhang, C. Y., Li, H., Zhang, S., Suharwardy, S., Chaturvedi, U., Fischer-Colbrie, T., Maratta, L. A., Onnela, J.-P., Coull, B. A., Hauser, R., Williams, M. A., Baird, D. D., Jukic, A. M. Z., Mahalingaiah, S., & Curry, C. L.
Affiliations
  • Apple (United States) (US)
  • Harvard University (US)
  • Stanford Medicine (US)
  • National Institutes of Health (US)
Corresponding author
Curry, Christine L.
Venue
American Journal of Obstetrics and Gynecology
Publisher
Elsevier BV
Published
2023-02
Volume
228
Issue
2
Pages
213.e1-213.e22
ISSN
0002-9378 (ISSN-L)
OpenAlex
W4307821025
Cited by
25
References
47
Citations by year
2026: 8 · 2025: 8 · 2024: 7 · 2023: 2
FWCI
3.75
Type
journal article
Language
en
Open access
Locations
  • American Journal of Obstetrics and Gynecology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion, cc-by-nc-nd)
Funders
  • U.S. Environmental Protection Agency
  • National Science Foundation
  • Apple Inc
  • National Institutes of Health
  • National Institute of Environmental Health Sciences (Z0ES049003, Z0ES1033333)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Keywords
abnormal uterine bleeding, menstrual tracking, menstrual irregularity, metrorrhagia, spotting, prevalence, obesity, body mass index, racial disparities, Black women, Apple Watch, menstrual health, hormonal contraception, oral contraceptives, hormonal IUD
MeSH terms
Adult, Endometriosis, Female, Humans, Menorrhagia, Menstruation Disturbances, Obesity, Polycystic Ovary Syndrome, Pregnancy, Women's Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review